Tuesday, September 15, 2026

U.S. Banks Urge Stronger Regulation on Stablecoins: What Does the Clarity Act Mean for 2026?

U.S. banks urge Senate to tighten stablecoin regulations, fearing interest-like rewards could destabilize local economies.

Korea Designated as Currency Watchlist Country: What This Means for the Economy in 2026

South Korea is redesignated as a currency watchlist country by the U.S. Treasury due to its trade and current account surpluses.

South Korea Moves to Approve $350 Billion US Investment Plan as Tariff Pressure Mounts

South Korea is advancing a Special Bill for U.S. investment, targeting $350 billion, while facing legislative hurdles and U.S. pressure.

Tag: development

Lunit Joins Global AI Consortium for Next-Gen Drug Development: What This Means for Precision Medicine

Lunit joins an AI consortium to enhance drug development through AI-driven pathology and biomarker analysis, collaborating with global firms.

Breakthrough in MASH Treatment: How miRNA-10a Outperforms Resmetirom in Fat Reduction

RXBio's miRNA-10a shows superior efficacy over Resmetirom in treating MASH, reducing fat, fibrosis, and inflammation significantly.

Samsung Electronics Launches Dedicated Robotics Division Under CEO to Accelerate Robot Business

Samsung Electronics is launching the RX Business Promotion Office to boost its robotics sector and develop AI-driven autonomous factories.

Kangstem Biotech Signs Organoid Technology Evaluation Agreement With Global Top Five Pharmaceutical Company

Kangstem Biotech has signed an agreement with a top pharmaceutical company to evaluate drug candidates using its hair follicle organoid platform.

Humanoid Robots Will Be Driven by Data, Not Just AI Models, Omdia Says: South Korea Could Become Alternative to U.S.-China Supply Chain

Data collection and ecosystem development are crucial for the humanoid robot industry's success, with South Korea as a potential third supply chain.

Unlocking the Future: Diden Robotics and Movin’s Breakthrough in Humanoid AI Motion Capture

Diden Robotics and Movin collaborate to enhance humanoid robots with precise human motion data for improved industrial applications.

Penetrium: The Next Breakthrough in Cancer Immunotherapy Starting Phase 2 Trials in the U.S.

Penetrium BioScience launches a Phase 2 clinical trial for Penetrium, targeting tumor microenvironments to enhance cancer immunotherapy.

Shaperon Secures South Korean Patent for Pulmonary Fibrosis Drug Candidate NuPulin

Shaperon secures a South Korean patent for NuPulin, an oral drug for idiopathic pulmonary fibrosis, showing promising preclinical results.

Grok 4.5 vs GPT-5.6: Which AI Model Will Dominate the Coding Market in 2026?

SpaceX AI launches Grok 4.5, an advanced AI model for coding, amid competition with OpenAI's upcoming GPT-5.6.

Interview: Huons’ PanGen Bets on ‘Development-Focused CDMO’ Strategy Built on Biosimilar Experience

South Korea's PanGen CDMO emphasizes development expertise and tailored services, enhancing drug development support for clients.

ABL Bio to Launch Global Phase 3 Trial of ABL111 in December, Targeting First-Line Gastric Cancer Treatment

ABL Bio will begin global Phase 3 trials for its dual antibody gastric cancer treatment 'ABL111' this December after FDA discussions.

Samsung Galaxy Unpacked: What to Expect from the New Foldable Smartphone?

Samsung Electronics is set to unveil a new foldable smartphone at Galaxy Unpacked, expanding its lineup with a unique form factor.

Bukwang Pharmaceutical builds turnaround momentum, eyes Parkinson’s drug progress in second half

Bukwang Pharmaceutical is advancing its Parkinson’s treatment CP-012 into a global Phase 2 trial while enhancing RNA technology and manufacturing.

SK Chemicals and J2H Biotech Partner for Breakthrough MASH Treatment: What You Need to Know

SK Chemicals partners with J2H Biotech to develop J2H-1702, a treatment for metabolic-associated steatotic liver disease, enhancing drug pipeline.

Top News

- Our Sponsors Ad -

Follow us